Guideline Updated for Initial Management of Advanced Prostate Cancer
Triplet therapy should be offered to patients with de novo metastatic noncastrate prostate cancer with high-volume disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.